MetLife Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $710K | Hold |
|
|||||
|
2025
Q2 | $658K | Hold |
|
|||||
|
2025
Q1 | $685K | Sell |
|
|||||
|
2024
Q4 | $525K | Buy |
|
|||||
|
2024
Q3 | $398K | Hold |
|
|||||
|
2024
Q2 | $756K | Buy |
|
|||||
|
2024
Q1 | $701K | Hold |
|
|||||
|
2023
Q4 | $809K | Hold |
|
|||||
|
2023
Q3 | $736K | Hold |
|
|||||
|
2023
Q2 | $961K | Buy |
|
|||||
|
2023
Q1 | $966K | Hold |
|
|||||
|
2022
Q4 | $914K | Hold |
|
|||||
|
2022
Q3 | $1.26M | Hold |
|
|||||
|
2022
Q2 | $1.38M | Hold |
|
|||||
|
2022
Q1 | $1.81M | Buy |
|
|||||
|
2021
Q4 | $917K | Hold |
|
|||||
|
2021
Q3 | $854K | Sell |
|
|||||
|
2021
Q2 | $1.02M | Hold |
|
|||||
|
2021
Q1 | $1.17M | Sell |
|
|||||
|
2020
Q4 | $1.11M | Hold |
|
|||||
|
2020
Q3 | $1.11M | Hold |
|
|||||
|
2020
Q2 | $971K | Hold |
|
|||||
|
2020
Q1 | $621K | Hold |
|
|||||
|
2019
Q4 | $838K | Hold |
|
|||||
|
2019
Q3 | $705K | Hold |
|
|||||
|
2019
Q2 | $805K | Hold |
|
|||||
|
2019
Q1 | $704K | Hold |
|
|||||
|
2018
Q4 | $796K | Hold |
|
|||||
|
2018
Q3 | $910K | Hold |
|
|||||
|
2018
Q2 | $593K | Hold |
|
|||||
|
2018
Q1 | $576K | Hold |
|
|||||
|
2017
Q4 | $845K | Buy |
|